Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

In vitro culture systems that parallel in vivo growth conditions are needed to study leukemia biology and to accurately test therapeutic efficacies. We investigated the effects of the HS-5 human bone marrow stromal cell line on cultured primary leukemia cell survival and chemosensitivity.A total of 30 bone marrow (BM) samples from untreated acute myeloid leukemia (AML) patients were cultured for 96 hours with serum and growth factors, without HS-5, or in direct contact with HS-5 monolayers, or with HS-5 separated from AML cells by transwell inserts. In some experiments, cytosine arabinoside or daunomycin was added for the last 18 hours of culture. Apoptosis frequencies, bcl-2 protein expression, proliferating cell nuclear antigen expression, and cell cycle distributions were determined in four-color flow cytometry analyses of CD45(+) leukemia cells. In comparison to control growth conditions, direct contact with HS-5 significantly inhibited culture-induced and drug-induced apoptosis of AML cells. Direct contact of AML cells with HS-5 significantly increased short-term proliferation and viability, and colony formation of primary AML cells. HS-5-mediated apoptosis inhibition was not consistently associated with increased bcl-2 protein in AML cells. Noncontact conditions inhibited drug-induced apoptosis significantly less than direct contact with HS-5. Coculture of AML cells on HS-5 monolayers improved in vitro leukemia cell survival and attenuated chemotherapy-induced leukemia cell killing. This has practical significance, increasing the fraction of primary AML samples that can be analyzed in vitro, and allows drug sensitivity testing in growth conditions more similar to the bone marrow microenvironment.

[1]  D. Spierings,et al.  β1‐integrins dominate cell traffic of leukemic cells in human bone‐marrow stroma , 1996, International journal of cancer.

[2]  John Calvin Reed,et al.  Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells , 1997, Leukemia.

[3]  J. Vose,et al.  Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival. , 1998, Leukemia & lymphoma.

[4]  Y. Hannun,et al.  Apoptosis and the dilemma of cancer chemotherapy. , 1997, Blood.

[5]  D. Cheresh,et al.  Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Rafii,et al.  Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. , 1995, Blood.

[7]  A. G. Bosanquet,et al.  Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies. , 1986, Leukemia research.

[8]  L. Foroni,et al.  Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro , 1996, British journal of haematology.

[9]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[10]  H. Koeffler,et al.  An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). , 1980, Blood.

[11]  J. Liesveld,et al.  Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7. , 1996, Leukemia research.

[12]  B. Torok-Storb,et al.  Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. , 1995, Blood.

[13]  Richard J. Jones,et al.  Inhibited apoptosis and drug resistance in acute myeloid leukaemia , 1998, British Journal of Haematology.

[14]  H. Preisler.  Prediction of response to chemotherapy in acute myelocytic leukemia. , 1980, Blood.

[15]  I. Viano,et al.  In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non‐lymphocytic leukemia , 1989, Hematological oncology.

[16]  R. Pieters,et al.  DRUG SENSITIVITY ASSAYS IN LEUKAEMIA AND LYMPHOMA , 1990, British journal of haematology.

[17]  J. Radich,et al.  The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  E. Estey,et al.  Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  F. Appelbaum,et al.  Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples. , 2000, Cytometry.

[20]  F. Behm,et al.  Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.

[21]  M. Groudine,et al.  Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid Leukemia , 1997 .

[22]  O'Connor Pm,et al.  A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells , 1992 .

[23]  F. Behm,et al.  Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.

[24]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[25]  C. Taylor,et al.  Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. , 1989, British Journal of Cancer.

[26]  John Calvin Reed.  Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.

[27]  J. Liesveld,et al.  Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. , 1991, Experimental hematology.

[28]  M. Andreeff,et al.  Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  C. Schölzel,et al.  Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture. , 1985, Experimental hematology.

[30]  M. Schwartz,et al.  The extracellular matrix as a cell survival factor. , 1993, Molecular biology of the cell.

[31]  H. Preisler,et al.  Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay , 1984, British journal of haematology.

[32]  F. Behm,et al.  Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. , 1994, Blood.

[33]  F. Uckun.  Severe combined immunodeficient mouse models of human leukemia. , 1996, Blood.

[34]  E. Paietta.  Adhesion molecules in acute myeloid leukemia☆ , 1996, Leukemia Research.

[35]  I. Jinnai,et al.  Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells. , 1997, Experimental Hematology.

[36]  M. Groudine,et al.  Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. , 1998, Leukemia research.

[37]  L. Bendall,et al.  Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. , 1994, Experimental hematology.

[38]  L. Lagneaux,et al.  Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells , 1998 .